Michael Fanning has served as CEO of Vortex Surgical since its inception in January 2016. Prior to Vortex, Mike led Cleveland Clinic Foundation’s start-up Optoquest as CEO leading strategic initiatives for new biomedical technologies in ophthalmology. His 28 years of commercial/executive experience includes sales, management, marketing, new technology adoption, finance, M&A, investor relations, capital acquisition, and leadership. Mike served as VP of Sales for Synergetics USA, Inc. (acquired by Bausch and Lomb 2015) for 14 years, where he focused on people, processes, and products. Prior to his time at Synergetics, Mike spent 13 years at GE Capital in various senior auditing and management roles.